Literature DB >> 7905532

Peripheral vascular effects of beta-3 adrenergic receptor stimulation in conscious dogs.

Y T Shen1, H Zhang, S F Vatner.   

Abstract

To characterize the physiological function of the beta-3 adrenergic receptor subtype in vivo, the effects of a beta-3 adrenergic receptor agonist, BRL37344, were examined on systemic hemodynamics and regional blood flow distribution. They were compared with beta-1 or beta-2 adrenergic receptor stimulation using isoproterenol (ISO) in conscious dogs instrumented with aortic and left atrial catheters and ascending aortic flow probes. ISO, at a dose of 0.4 micrograms/kg/min i.v., reduced mean arterial pressure by 7 +/- 3% and increased total peripheral conductance by 145 +/- 12% and heart rate by 109 +/- 10%. BRL37344, at a dose of 8.3 micrograms/kg i.v., reduced mean arterial pressure by 9 +/- 4% and increased total peripheral conductance by 91 +/- 3% and heart rate by 63 +/- 5%. In the presence of selective beta-1 adrenergic receptor blockade with atenolol, ISO decreased mean arterial pressure by 20 +/- 5% and increased total peripheral conductance by 140 +/- 26% and heart rate by 60 +/- 12%. After combined beta-1 and beta-2 adrenergic receptor blockade with propranolol, ISO induced no significant effects. By contrast, after propranolol, BRL37344 still reduced mean arterial pressure by 13 +/- 2% and increased total peripheral conductance by 109 +/- 8% and heart rate by 45 +/- 5%. The beta-3 adrenergic receptor-mediated increase in total peripheral conductance (+146 +/- 8%) persisted after combined blockades, i.e., beta and alpha adrenergic, cholinergic, histaminergic, purinergic, prostaglandin and endothelium-derived relaxing factor blockades.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7905532

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  16 in total

Review 1.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

Review 2.  Cardiac β3 -adrenoceptors-A role in human pathophysiology?

Authors:  Ebru Arioglu-Inan; Gizem Kayki-Mutlu; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-22       Impact factor: 8.739

3.  Characterization of the adrenergic activity of arbutamine, a novel agent for pharmacological stress testing.

Authors:  G Abou-Mohamed; R Nagarajan; T M Ibrahim; R W Caldwell
Journal:  Cardiovasc Drugs Ther       Date:  1996-03       Impact factor: 3.727

4.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

5.  Increased Ca2+ sensitivity and protein expression of SERCA 2a in situations of chronic beta3-adrenoceptor deficiency.

Authors:  Christoph Ziskoven; Sabrina Grafweg; Birgit Bölck; Rudolf J Wiesner; Maria Jimenez; Jean-Paul Giacobino; W Bloch; Robert H G Schwinger; Klara Brixius
Journal:  Pflugers Arch       Date:  2006-09-22       Impact factor: 3.657

6.  Biphasic effects of the beta-adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle.

Authors:  Y L Liu; M A Cawthorne; M J Stock
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

7.  Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.

Authors:  J N Trochu; V Leblais; Y Rautureau; F Bévérelli; H Le Marec; A Berdeaux; C Gauthier
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

8.  Functional, biochemical and molecular biological evidence for a possible beta(3)-adrenoceptor in human near-term myometrium.

Authors:  M Bardou; C Loustalot; J Cortijo; B Simon; E Naline; M Dumas; S Esteve; T Croci; P Chalon; R Frydman; P Sagot; L Manara; E J Morcillo; C Advenier
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

9.  Mediation of the positive chronotropic effect of CGP 12177 and cyanopindolol in the pithed rat by atypical beta-adrenoceptors, different from beta 3-adrenoceptors.

Authors:  B Malinowska; E Schlicker
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

10.  In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.

Authors:  P Barbe; L Millet; J Galitzky; M Lafontan; M Berlan
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.